These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35284389)

  • 1. EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation.
    Kwan YH; Yoon S; Tan CS; Tai BC; Tan WB; Phang JK; Tan NC; Tan CYL; Quah YL; Koot D; Teo HH; Low LL
    Front Public Health; 2022; 10():805856. PubMed ID: 35284389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empowering patients with comorbid diabetes and hypertension through a multi-component intervention of mobile app, health coaching and shared decision-making: Protocol for an effectiveness-implementation of randomised controlled trial.
    Kwan YH; Yoon S; Tai BC; Tan CS; Phang JK; Tan WB; Tan NC; Tan CYL; Koot D; Quah YL; Teo HH; Low LL
    PLoS One; 2024; 19(2):e0296338. PubMed ID: 38408067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.
    Huang F; Wu X; Xie Y; Liu F; Li J; Li X; Zhou Z
    Trials; 2020 Nov; 21(1):944. PubMed ID: 33225982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients - design of a randomised controlled trial ('TRIGGER study').
    Boels AM; Rutten G; Zuithoff N; de Wit A; Vos R
    BMC Endocr Disord; 2018 Oct; 18(1):74. PubMed ID: 30348142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial.
    Lee EY; Cha SA; Yun JS; Lim SY; Lee JH; Ahn YB; Yoon KH; Hyun MK; Ko SH
    J Med Internet Res; 2022 Jul; 24(7):e37430. PubMed ID: 35900817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Save Medical Corporation (SMC)-01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial.
    Leung N; Waki K; Nozoe S; Enomoto S; Saito R; Hamagami S; Yamauchi T; Nangaku M; Ohe K; Onishi Y
    J Med Internet Res; 2024 Sep; 26():e53740. PubMed ID: 39255478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial.
    Tang H; Qin H; Zhang M; Zhang J; Tan H; Chen M; Kong L; Guo M; Hu F; Wang Q; Wang X; Zhang K; Xiong Z
    Trials; 2023 Jul; 24(1):468. PubMed ID: 37480092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health effects of reduced occupational sedentary behaviour in type 2 diabetes using a mobile health intervention: a study protocol for a 12-month randomized controlled trial-the ROSEBUD study.
    Syrjälä MB; Bennet L; Dempsey PC; Fharm E; Hellgren M; Jansson S; Nilsson S; Nordendahl M; Rolandsson O; Rådholm K; Ugarph-Morawski A; Wändell P; Wennberg P
    Trials; 2022 Jul; 23(1):607. PubMed ID: 35897022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart Phone APP to Restore Optimal Weight (SPAROW): protocol for a randomised controlled trial for women with recent gestational diabetes.
    Lim K; Chi C; Chan SY; Lim SL; Ang SM; Yoong JS; Tsai C; Wong SR; Yew TW; Tai ES; Yong EL
    BMC Public Health; 2019 Oct; 19(1):1287. PubMed ID: 31615456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based lifestyle intervention for diabetes (Co-LID study) management rural Nepal: study protocol for a clustered randomized controlled trial.
    Rawal L; Dahal P; Paudel G; Biswas T; Shrestha R; Makaju D; Shrestha A; Yadav U; Sahle BW; Iwashita H; Masuda G; Renzaho A; Shakya P; Shrestha A; Karmacharya B; Sakamoto H; Koju R; Sugishita T
    Trials; 2023 Jul; 24(1):441. PubMed ID: 37403179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a smartphone application (KAIA COPD app) in combination with Activity Monitoring as a maintenance prOgram following PUlmonary Rehabilitation in COPD: the protocol for the AMOPUR Study, an international, multicenter, parallel group, randomized, controlled study.
    Spielmanns M; Boeselt T; Huber S; Kaur Bollinger P; Ulm B; Peckaka-Egli AM; Jarosch I; Schneeberger T; Schoendorf S; Gloeckl R; Koczulla AR
    Trials; 2020 Jul; 21(1):636. PubMed ID: 32653025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Wearable Technology Delivering a Web-Based Diabetes Prevention Program to People at High Risk of Type 2 Diabetes: Randomized Controlled Trial.
    Staite E; Bayley A; Al-Ozairi E; Stewart K; Hopkins D; Rundle J; Basudev N; Mohamedali Z; Ismail K
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e15448. PubMed ID: 32459651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Artificial Intelligence-based Health Education Accurately Linking System (AI-HEALS) for Type 2 diabetes self-management: protocol for a mixed-methods study.
    Wu Y; Min H; Li M; Shi Y; Ma A; Han Y; Gan Y; Guo X; Sun X
    BMC Public Health; 2023 Jul; 23(1):1325. PubMed ID: 37434126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
    Suleiman N; Alkasem M; Al Amer Z; Salameh O; Al-Thani N; Hamad MK; Baagar K; Abdalhakam I; Othman M; Dughmosh R; Al-Mohanadi D; Al Sanousi A; Bashir M; Chagoury O; Taheri S; Abou-Samra AB
    Trials; 2022 Jun; 23(1):504. PubMed ID: 35710428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Behavioral Mobile Phone App Intervention for the Self-Management of Type 2 Diabetes: Randomized Controlled Trial Protocol.
    Goyal S; Lewis G; Yu C; Rotondi M; Seto E; Cafazzo JA
    JMIR Res Protoc; 2016 Aug; 5(3):e174. PubMed ID: 27542325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized wait-list control trial to evaluate the impact of a mobile application to improve self-management of individuals with type 2 diabetes: a study protocol.
    Desveaux L; Agarwal P; Shaw J; Hensel JM; Mukerji G; Onabajo N; Marani H; Jamieson T; Bhattacharyya O; Martin D; Mamdani M; Jeffs L; Wodchis WP; Ivers NM; Bhatia RS
    BMC Med Inform Decis Mak; 2016 Nov; 16(1):144. PubMed ID: 27842539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu K; Xie Z; Or CK
    JMIR Mhealth Uhealth; 2020 Aug; 8(8):e15779. PubMed ID: 32459654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives.
    Lim RSM; Gardner DSL; Bee YM; Cheung YB; Bairavi J; Gandhi M; Goh SY; Ho ETL; Lin X; Tan NC; Tay TL; Finkelstein EA
    Trials; 2019 Nov; 20(1):650. PubMed ID: 31779678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fukushima study for Engaging people with type 2 Diabetes in Behaviour Associated Change (FEEDBACK): study protocol for a cluster randomised controlled trial.
    Rouyard T; Endo M; Nakamura R; Moriyama M; Stanyon M; Kanke S; Nakamura K; Chen C; Hara Y; Ii M; Kassai R
    Trials; 2023 May; 24(1):317. PubMed ID: 37158959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.
    Höchsmann C; Walz SP; Schäfer J; Holopainen J; Hanssen H; Schmidt-Trucksäss A
    Trials; 2017 Mar; 18(1):103. PubMed ID: 28264717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.